BOSTON, June 5, 2012 /PRNewswire via COMTEX/ -- Ranked in the Top 4 in all 10 Specialty Areas

Boston Children's Hospital ranks first in the U.S. News & World Report's 2012-13 Best Children's Hospitals Rankings Honor Roll. With evaluation results released today, Boston Children's is first in Cardiology & Heart Surgery, Nephrology, Neurology & Neurosurgery; second in Cancer, Diabetes & Endocrinology, Gastroenterology and Urology; third in Neonatology and Orthopedics; and fourth in Pulmonology. Boston Children's partners with Dana-Farber Cancer Institute to operate the Dana-Farber/Children's Hospital Cancer Center - an integrated pediatric oncology program.

"We're honored by this recognition and view it as a challenge to continue to work tirelessly to improve the quality of care given to each and every family that comes through our doors," says James Mandell, MD, CEO of Boston Children's.

The rankings feature 50 hospitals in each of 10 pediatric specialties: cancer, cardiology and heart surgery, diabetes and endocrinology, gastroenterology, neonatology, nephrology, neurology and neurosurgery, orthopedics, pulmonology, and urology. Eighty hospitals across the country ranked in one or more specialties. Among hospitals in Massachusetts, Boston Children's was the only hospital ranked in the top 30 in any of the specialty areas.

"The rankings reflect the dedication of our caregivers, researchers, staff, volunteers and referring doctors across Boston Children's community of care," adds Sandra Fenwick, President and COO of Boston Children's. "Our staff represents the finest in their fields, and it's only through working together that we can provide such exceptional care."

This year, U.S. News surveyed 178 pediatric centers to obtain hard data such as availability of key resources and ability to prevent complications and infections. The hospital survey made up 75 percent of the evaluation to determine rankings. A separate reputational survey in which 1,500 pediatric specialists--150 in each specialty--were asked where they would send the sickest children in their specialty made up the remaining 25 percent of data used for evaluation.

Founded in 1869 as a 20-bed hospital for children, Boston Children's Hospital has been ranked as one of the nation's best pediatric hospitals by U.S.News & World Report for the past 21 years. Boston Children's is the primary pediatric teaching hospital of Harvard Medical School and the largest provider of health care to Massachusetts children. In addition to 395 pediatric and adolescent inpatient beds and 228 outpatient programs, Boston Children's houses the world's largest research enterprise based at a pediatric medical center, where its discoveries benefit both children and adults. More than 1,100 scientists, including nine members of the National Academy of Sciences, 11 members of the Institute of Medicine and nine members of the Howard Hughes Medical Institute comprise Boston Children's research community. For more information about the hospital visit: www.childrenshospital.org/newsroom .

CONTACT:Rob GrahamBoston Children's Hospital This e-mail address is being protected from spambots. You need JavaScript enabled to view it

SOURCE Boston Children's Hospital

Copyright (C) 2012 PR Newswire. All rights reserved

...

BOSTON—Preemptive kidney transplantation may offer no survival advantage over kidney transplantation soon after dialysis initiation, according to new findings reported at the 2012 American Transplant Congress.

Researchers at Johns Hopkins University in Baltimore studied 24,233 adult first-time recipients of deceased donor kidney transplants (DDKT), of whom 9,924 received preemptive transplants and 14,309 received their organs within one year of starting dialysis. The investigators found no significant difference in mortality between these two groups, after adjusting for age, race, gender, and insurance status.

Preemptive transplant recipients were significantly older than those who received their transplants within a year of starting dialysis (53 vs. 50.9 years) and significantly more likely to be female than male (44% vs. 38%), white than nonwhite (74% vs. 68%), and privately insured (62% vs. 51% for patients without private insurance).

The authors concluded that their findings raise questions about the ethics of allocating a scarce resource to patients who are not yet on dialysis.

Of the 116,395 patients who started treatment for end-stage renal disease (ESRD) in 2009, 2,759 had a preemptive renal transplant as their first ESRD treatment modality, according to the 2011 U.S. Renal Data System Annual Data Report.

...

KANSAS CITY, Mo., June 5, 2012 /PRNewswire via COMTEX/ -- Children's Mercy Hospitals and Clinics ranks among the nation's top pediatric hospitals, according to U.S. News and World Report's 2012-13 "Best Children's Hospitals" rankings. For the second year in a row, the hospital is one of only a small number to be ranked in all 10 specialties.

The rankings feature 50 hospitals in each of 10 pediatric specialties: nephrology (#6), cancer (#36), cardiology and heart surgery (#39), diabetes and endocrinology (#34), gastroenterology (#30), neonatology (#32), neurology and neurosurgery (#42), orthopedics (#31), pulmonology (#48), and urology (#32).

"We are proud of the quality care our entire Children's Mercy staff provides each day; their compassion and commitment is truly unmatched. Being recognized among the nation's best children's hospitals for the fifth consecutive year and second year in all 10 specialties is a testament to their work," says Children's Mercy president and CEO, Randall L. O'Donnell, PhD.

This year, U.S. News surveyed 178 pediatric centers to obtain hard data such as availability of key resources and ability to prevent complications and infections. The hospital survey made up 75 percent of the rankings. A separate reputational survey in which 1,500 pediatric specialists--150 in each specialty--were asked where they would send the sickest children in their specialty made up the remaining 25 percent.

The full rankings and methodology are available at www.usnews.com/childrenshospitals . The rankings will also be published in the U.S. News Best Hospitals 2013 guidebook, which will be available in August.

About Children's Mercy Hospitals and Clinics

Children's Mercy Hospitals and Clinics, located in Kansas City, Mo., is one of the nation's top pediatric medical centers. The 319-bed hospital provides care for children from birth through the age of 18, has been ranked by U.S. News & World Report as one of "America's Best Children's Hospitals," and recognized by the American Nurses Credentialing Center with Magnet designation for excellence in nursing services. Its faculty of 600 pediatricians and researchers across more than 40 subspecialties are actively involved in clinical care, pediatric research, and educating the next generation of pediatric subspecialists. For more information about Children's Mercy and its research, visit childrensmercy.org or download our mobile phone app CMH4YOU for all phone types. For breaking news and videos, follow us on Twitter, YouTube and Facebook.

        Contact: Melissa Novak
        Phone:   (816) 346-1341
        E-Mail:  
 This e-mail address is being protected from spambots. You need JavaScript enabled to view it
 
        Website: ChildrensMercy.org
        

SOURCE Children's Mercy Hospitals and Clinics

Copyright (C) 2012 PR Newswire. All rights reserved

...

Dallas, TX -- (SBWIRE) -- 06/05/2012 -- GlobalData’s new report, “Middle East and Africa Nephrology and Urology Devices Market Outlook to 2018 - Incontinence Devices, Renal Dialysis Equipment and Lithotripters” provides key market data on the Middle East and Africa Nephrology and Urology Devices market – Israel, Saudi Arabia and South Africa. The report provides value (USD million) data for all the market categories – Incontinence Devices, Lithotripters and Renal Dialysis Equipment. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

1. Countries covered include Israel, Saudi Arabia and South Africa.
2. Market size and company share data for Nephrology and Urology Devices market categories – Incontinence Devices, Lithotripters and Renal Dialysis Equipment.
3. Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018.
4. 2011 company shares and distribution shares data for each of the market categories and countries.
5. Global corporate-level profiles of key companies operating within the Middle East and Africa Nephrology and Urology Devices market..
6. Key players covered include Fresenius Medical Care AG & Co. KGaA, Gambro AB, Svenska Cellulosa Aktiebolaget SCA, HARTMANN GROUP, Kimberly-Clark Corporation, B. Braun Melsungen AG and others.

Reasons to Buy

Develop business strategies by identifying the key market categories and segments poised for strong growth.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the Middle East and Africa Nephrology and Urology Devices competitive landscape.

Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Buy your copy of this report @ http://www.reportsnreports.com/reports/160364-middle-east-and-africa-nephrology-and-urology-devices-market-outlook-to-2018-incontinence-devices-renal-dialysis-equipment-and-lithotripters.html .

List Of Tables

Table 1: Nephrology and Urology Devices, Cross Country Comparison, Revenue ($m),USD Constant, 2004-2018 11
Table 2: Nephrology and Urology Devices, Middle East and Africa, Overall Revenue ($m), USD Constant, 2004-2018 13
Table 3: Nephrology and Urology Devices, Middle East and Africa, Cross-Category Analysis, 2004-2018 15
Table 4: Nephrology and Urology Devices, Middle East and Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011 17
Table 5: Nephrology and Urology Devices, Middle East and Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 19
Table 6: Nephrology and Urology Devices, Middle East and Africa, Company share by Revenue ($m), USD Constant, 2010-2011 21
Table 7: Nephrology and Urology Devices, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 23
Table 8: Nephrology and Urology Devices, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011 25
Table 9: Nephrology and Urology Devices, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 27
Table 10: Incontinence Devices, South Africa, Distribution Share by Revenue ($m), USD Constant, 2010-2011 28
Table 11: Lithotripters, South Africa, Distribution Share by Revenue ($m), USD Constant, 2010-2011 28
Table 12: Renal Dialysis Equipment, South Africa, Distribution Share by Revenue ($m), USD Constant, 2010-2011 29
Table 13: Nephrology and Urology Devices, South Africa, Company Share by Revenue ($m), USD Constant, 2010-2011 31
Table 14: Incontinence Devices, South Africa, Company Share by Revenue ($m), USD Constant, 2010-2011 33
Table 15: Lithotripters, South Africa, Company Share by Revenue ($m), USD Constant, 2010-2011 34
Table 16: Renal Dialysis Equipment, South Africa, Company Share by Revenue ($m), USD Constant, 2010-2011 36
Table 17: Nephrology and Urology Devices, Israel, Overall Revenue ($m), USD Constant, 2004-2018 38
Table 18: Nephrology and Urology Devices, Israel, Overall Revenue ($m), USD Constant, Historic, 2004-2011 40
Table 19: Nephrology and Urology Devices, Israel, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 42
Table 20: Incontinence Devices, Israel, Distribution Share by Revenue ($m), USD Constant, 2010-2011 43
Table 21: Lithotripters, Israel, Distribution Share by Revenue ($m), USD Constant, 2010-2011 43
Table 22: Renal Dialysis Equipment, Israel, Distribution Share by Revenue ($m), USD Constant, 2010-2011 44
Table 23: Nephrology and Urology Devices, Israel, Company Share by Revenue ($m), USD Constant, 2010-2011 46
Table 24: Incontinence Devices, Israel, Company Share by Revenue ($m), USD Constant, 2010-2011 48
Table 25: Lithotripters, Israel, Company Share by Revenue ($m), USD Constant, 2010-2011 49
Table 26: Renal Dialysis Equipment, Israel, Company Share by Revenue ($m), USD Constant, 2010-2011 50
Table 27: Nephrology and Urology Devices, Saudi Arabia, Overall Revenue ($m), USD Constant, 2004-2018 52
Table 28: Nephrology and Urology Devices, Saudi Arabia, Overall Revenue ($m), USD Constant, Historic, 2004-2011 54
Table 29: Nephrology and Urology Devices, Saudi Arabia, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 56
Table 30: Incontinence Devices, Saudi Arabia, Distribution Share by Revenue ($m), USD Constant, 2010-2011 57
Table 31: Lithotripters, Saudi Arabia, Distribution Share by Revenue ($m), USD Constant, 2010-2011 57
Table 32: Renal Dialysis Equipment, Saudi Arabia, Distribution Share by Revenue ($m), USD Constant, 2010-2011 58
Table 33: Nephrology and Urology Devices, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010-2011 60
Table 34: Incontinence Devices, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010-2011 62
Table 35: Lithotripters, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010-2011 63
Table 36: Renal Dialysis Equipment, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010-2011 65
Table 37: Nephrology and Urology Devices Market Pipeline Products 78

List of Figures

Figure 1: Nephrology and Urology Devices, Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018 11
Figure 2: Nephrology and Urology Devices, Middle East and Africa, Overall Revenue ($m), USD Constant, 2004-2018 12
Figure 3: Nephrology and Urology Devices, Middle East and Africa, Cross-Category Analysis, 2004-2018 14
Figure 4: Nephrology and Urology Devices, Middle East and Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011 16
Figure 5: Nephrology and Urology Devices, Middle East and Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 18
Figure 6: Nephrology and Urology Devices, Middle East and Africa, Company share (%), 2011 20
Figure 7: Nephrology and Urology Devices, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 22
Figure 8: Nephrology and Urology Devices, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011 24
Figure 9: Nephrology and Urology Devices, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 26
Figure 10: Nephrology and Urology Devices, South Africa, Company Share (%), 2011 30
Figure 11: Incontinence Devices, South Africa, Company Share (%), 2011 32
Figure 12: Lithotripters, South Africa, Company Share (%), 2011 34
Figure 13: Renal Dialysis Equipment, South Africa, Company Share (%), 2011 35
Figure 14: Nephrology and Urology Devices, Israel, Overall Revenue ($m), USD Constant, 2004-2018 37
Figure 15: Nephrology and Urology Devices, Israel, Overall Revenue ($m), USD Constant, Historic, 2004-2011 39
Figure 16: Nephrology and Urology Devices, Israel, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 41
Figure 17: Nephrology and Urology Devices, Israel, Company Share (%) (2010-2011) 45
Figure 18: Incontinence Devices, Israel, Company Share (%), 2011 47
Figure 19: Lithotripters, Israel, Company Share (%), 2011 49
Figure 20: Renal Dialysis Equipment, Israel, Company Share (%), 2011 50
Figure 21: Nephrology and Urology Devices, Saudi Arabia, Overall Revenue ($m), USD Constant, 2004-2018 51
Figure 22: Nephrology and Urology Devices, Saudi Arabia, Overall Revenue ($m), USD Constant, Historic, 2004-2011 53
Figure 23: Nephrology and Urology Devices, Saudi Arabia, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 55
Figure 24: Nephrology and Urology Devices, Saudi Arabia, Company Share (%), 2011 59
Figure 25: Incontinence Devices, Saudi Arabia, Company Share (%), 2011 61
Figure 26: Lithotripters, Saudi Arabia, Company Share (%), 2011 63
Figure 27: Renal Dialysis Equipment, Saudi Arabia, Company Share (%), 2011 64
Figure 28: Fresenius Medical Care AG & Co. KGaA, Company Share (%), Middle East and Africa Nephrology and Urology Devices Market, 2011 66
Figure 29: Gambro AB, Company Share (%), Middle East and Africa Nephrology and Urology Devices Market, 2011 67
Figure 30: Svenska Cellulosa Aktiebolaget SCA, Company Share (%), Middle East and Africa Nephrology and Urology Devices Market, 2011 68
Figure 31: HARTMANN GROUP, Company Share (%), Middle East and Africa Nephrology and Urology Devices Market, 2011 69
Figure 32: Kimberly-Clark Corporation, Company Share (%), Middle East and Africa Nephrology and Urology Devices Market, 2011 70
Figure 33: B. Braun Melsungen AG, Company Share (%), Middle East and Africa Nephrology and Urology Devices Market, 2011 71

Contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it for further information.

...